Recce Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 23, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	121	55	82	74	109	121
Market Cap Growth	82.01%	-32.86%	10.13%	-31.93%	-10.10%	92.50%
Enterprise Value	121	57	81	73	98	104
Last Close Price	0.22	0.22	0.60	0.46	-	-
PS Ratio	24.58	11.14	24.34	25.52	51.25	98.70
PB Ratio	-60.48	-27.40	-12.85	-43.03	15.71	7.88
P/TBV Ratio	-	-	-	-	15.71	7.88
EV/Sales Ratio	22.73	11.51	24.03	25.13	46.16	84.42
Debt / Equity Ratio	-3.53	-3.53	-1.10	-1.27	0.01	0.01
Asset Turnover	0.80	0.80	1.13	0.57	0.18	0.13
Quick Ratio	1.78	1.78	0.30	0.34	4.81	19.59
Current Ratio	1.86	1.86	0.34	0.40	4.98	19.64
Return on Equity (ROE)	-	-	-	-350.01%	-71.89%	-118.45%
Return on Assets (ROA)	-135.80%	-135.80%	-238.05%	-106.04%	-35.15%	-67.74%
Return on Capital Employed (ROCE)	-324.70%	-324.70%	195.40%	561.40%	-94.80%	-65.60%
Earnings Yield	-11.61%	-25.62%	-14.43%	-11.74%	-6.95%	-8.36%
FCF Yield	-11.09%	-24.48%	-10.75%	-11.42%	-5.72%	-4.91%
Buyback Yield / Dilution	-33.81%	-33.81%	-1.79%	0.09%	-12.05%	-22.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.